Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) insider Paul R. Edick bought 10,000 shares of Xeris Biopharma stock in a transaction that occurred on Wednesday, August 9th. The shares were bought at an average cost of $2.38 per share, with a total value of $23,800.00. Following the acquisition, the insider now directly owns […]